SCHEMBL14765137

SCHEMBL14765137

Cc1nc2ccccc2n2c(Cc3ccc(Cl)cc3)nnc12

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 14/20 0.56
PDE10A Q9Y233 12/20 0.56
GALR3 O60755 1/20 0.49
NR2F2 P24468 1/20 0.49
RAB9A P51151 1/20 0.49
HTR2C P28335 1/20 0.48
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14765127 0.77 PDE2A (0.53) PDE2APDE10AHTR2C
SCHEMBL14354843 0.74 POLB (0.54) PDE2APDE10AHTR2CMEN1KMT2A
SCHEMBL12502583 0.72 PDE2A (1.00) PDE2APDE10A
SCHEMBL8022214 0.71 LMNA (0.79) GALR3NR2F2RAB9AMEN1LMNA
SCHEMBL12502893 0.70 PDE2A (1.00) PDE2APDE10AMAOAMAOB
SCHEMBL14054782 0.70 PDE2A (0.67) PDE2APDE10AMEN1KMT2A
SCHEMBL7340895 0.70 HTR2C (0.66) HTR2CMEN1TP53MAPTKMT2A
SCHEMBL14764776 0.69 TYMS (0.70) PDE2APDE10AMAOAMEN1KMT2A
SCHEMBL13187013 0.69 LMNA (0.85) GALR3NR2F2RAB9AMEN1LMNA
SCHEMBL14362116 0.68 PDE2A (0.76) PDE2APDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 WO claimed
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 WO disclosed
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 WO disclosed